Amneal Pharmaceuticals, Inc. (AMRX) vs Hinge Health, Inc. (HNGE)
A side-by-side comparison of Amneal Pharmaceuticals, Inc. and Hinge Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMRX
Amneal Pharmaceuticals, Inc.
$20.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HNGE
Hinge Health, Inc.
$98.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AMRX vs HNGE
growth of $100 · dividends reinvested · last 1yAMRX +174.3% (+174.3%/yr)HNGE +161.8% (+161.8%/yr)AMRX compounded faster over this window
AMRX HNGE
AMRX vs HNGE: by the numbers
- •HNGE is the larger company ($7.61B vs $6.48B market cap).
- •AMRX trades at the lower trailing earnings multiple (41.63 vs 76.44 P/E), one valuation lens rather than an overall verdict.
- •HNGE converts more revenue to profit (15.15% vs 5.05% net margin).
Metrics side by side
Valuation
| Metric | AMRX | HNGE |
|---|---|---|
| P/E ratio | 41.63 | 76.44 |
| Forward P/E | 19.82 | 42.41 |
| P/S ratio | 2.08 | 10.57 |
| P/B ratio | 196.25 | 22.10 |
| EV / EBITDA | 15.30 | 75.03 |
| FCF yield | 1.28% | 3.78% |
Profitability
| Metric | AMRX | HNGE |
|---|---|---|
| Gross margin | 39.32% | 84.52% |
| Operating margin | 12.93% | -92.94% |
| Net margin | 5.05% | 15.15% |
| ROE | 476.51% | 31.68% |
| ROIC | 13.45% | 26.62% |
Growth (annualized)
| Metric | AMRX | HNGE |
|---|---|---|
| Revenue CAGR (5Y) | 8.67% | N/A |
| EPS CAGR (5Y) | -17.72% | N/A |
| FCF CAGR (5Y) | -14.46% | N/A |
| Total return CAGR (5Y) | 30.25% | N/A |
Frequently asked
- Which has the lower trailing P/E, AMRX or HNGE?
- AMRX has the lower trailing P/E: AMRX trades at 41.63 and HNGE at 76.44. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is AMRX or HNGE more profitable?
- HNGE runs the higher net margin — AMRX at 5.05% versus HNGE at 15.15%.
Go deeper
Dig into the metrics
Amneal Pharmaceuticals P/E ratioHinge Health P/E ratioAmneal Pharmaceuticals ROEHinge Health ROEAmneal Pharmaceuticals operating marginHinge Health operating marginAmneal Pharmaceuticals revenue growthHinge Health revenue growthAmneal Pharmaceuticals free cash flowHinge Health free cash flow
Amneal Pharmaceuticals & Hinge Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.